T2-FLAIR Hyperintense Brain Lesions: Evaluation and Management
A T2-FLAIR hyperintense brain lesion requires systematic evaluation starting with confirmation on multiple imaging planes, assessment of location and morphology, and correlation with clinical presentation to differentiate between demyelinating disease (most commonly multiple sclerosis), vascular disease, infection, neoplasm, or other etiologies.
Initial Imaging Approach
When you encounter a T2-FLAIR hyperintense lesion, first confirm it's a true lesion and not an artifact by verifying it on multiple planes 1. The lesion should be at least 3 mm in its longest axis to be diagnostically significant, though smaller lesions in critical locations (like the floor of the fourth ventricle) should still be considered abnormal 1.
Core MRI Protocol Requirements
Your imaging workup should include 2:
- 3D T2-FLAIR sequences (preferred over 2D) for optimal lesion identification
- T2-weighted sequences to confirm posterior fossa lesions
- Susceptibility-sensitive sequences for central vein sign identification
- Post-gadolinium T1-weighted sequences (after 5-minute delay) to detect enhancement
- Spatial resolution: Maximum 1×1 mm in-plane resolution at 1.5T or 3T
Location-Based Differential Diagnosis
For Multiple Sclerosis Consideration
Look for lesions in characteristic locations 2, 1:
- Periventricular (abutting lateral ventricles)
- Juxtacortical (touching cortex)
- Infratentorial (brainstem/cerebellum)
- Spinal cord (cervical + thoracic)
MS diagnosis requires at least one typical lesion in at least two of these characteristic regions 1. MS lesions are typically ovoid, oriented perpendicular to ventricles, and range from a few millimeters to >2 cm 1.
For Mesial Temporal Lobe Lesions
T2-FLAIR hyperintensity here demands consideration of 3:
- Infectious: Herpes simplex encephalitis (most common), HHV-6, Japanese encephalitis, neurosyphilis
- Autoimmune: Autoimmune encephalitis
- Vascular: Bilateral or paradoxical PCA infarction
- Seizure-related: Status epilepticus, hippocampal sclerosis
- Neoplastic: Gliomatosis cerebri
For Non-Enhancing Lesions Distant from Tumor
In patients with known CNS lymphoma, non-enhancing T2-FLAIR hyperintense lesions distant from enhancing tumor occur in 11.5% of cases and are potentially neoplastic 4. These patients more commonly have multiple bilateral enhancing lesions at baseline 4.
Critical Diagnostic Features
Lesion Morphology Assessment
Evaluate these characteristics 1:
- Size: Generally ≥3 mm in long axis
- Shape: Round to ovoid (MS-typical)
- Orientation: Perpendicular to ventricles (Dawson's fingers in MS)
- T1 characteristics: Hypointensity suggests more destructive pathology
- Enhancement pattern: Transient enhancement (2-8 weeks, typically 4 weeks) suggests MS 1
Enhancement Patterns Matter
Administer gadolinium on initial evaluation to detect enhancing lesions and evaluate differential diagnoses 2. The presence of both enhancing and non-enhancing lesions simultaneously fulfills dissemination in time criteria for MS 2.
Comprehensive Workup Strategy
Initial Evaluation
- Brain AND whole spinal cord imaging at diagnosis 2
- Gadolinium administration on first scan only (repeat scans can be done without contrast as new T2-FLAIR lesions suffice for demonstrating dissemination in time) 2
- Fat-suppressed optic nerve imaging in atypical cases 1
Follow-up Imaging
- Repeat brain imaging without gadolinium is sufficient, as new T2-FLAIR lesions demonstrate disease progression 2
- Spinal cord repeat imaging not routinely needed (isolated new cord lesions without brain lesions are rare) 2
- Use consistent slice positioning along subcallosal line and image registration for accurate comparison 2
Common Pitfalls to Avoid
False Positives
Periventricular and perivascular T2-FLAIR hyperintensities overestimate actual demyelination 5. Increased blood-brain barrier permeability and plasma leakage in aging can cause T2-FLAIR signal despite minimal demyelination 5. Small, rounded deep white matter lesions sparing periventricular zones and U-fibers are often non-specific and related to vascular disease or normal aging 1.
False Negatives
Deep white matter demyelination is underestimated on T2-FLAIR 5. Always confirm lesions on multiple sequences and planes 1.
Misinterpretation of Non-Enhancing Lesions
In primary CNS lymphoma, don't dismiss non-enhancing T2-FLAIR hyperintense lesions distant from the main tumor—these may represent tumor burden requiring incorporation into treatment planning 4.
When to Pursue Tissue Diagnosis
Consider biopsy when:
- Imaging features are atypical for common etiologies
- Clinical presentation doesn't match radiologic findings
- Lesions progress despite appropriate treatment
- Single lesion in unusual location without clear etiology
Interpretation should be performed by trained neuroradiologists or clinicians deeply familiar with MS and its differential diagnoses 1.
Special Considerations
Pregnancy and Contrast
Gadolinium should be avoided in pregnancy unless clinically essential 2. Macrocyclic gadolinium agents are preferred due to less deposition risk and are considered safe during breastfeeding 2.
Serial Imaging Value
T2 lesions can increase, decrease, stabilize, or rarely completely disappear over time 1. Serial imaging supports MS diagnosis by demonstrating lesion accrual over time and in new CNS areas 1.